CytomX Therapeutics shares yo-yoed this past week, surging on positive early clinical data for its colorectal cancer candidate, then retreating on investor questions about the data. Also, Eli Lilly ...

A cross-sectional NHANES study of 2,582 U.S. women found that higher ultra-processed food intake was associated with lower ...

Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the U.S. FDA has approved Restylane ...

A clinical decision support tool that uses artificial intelligence (AI) to analyze scans after a stroke alongside treatment ...

The community-based opioid treatment program Honor's HEROES at UTHealth Houston may significantly improve treatment retention ...